Source Search Page

biopharma-reporter.com > article

Evaxion’s AI-immunology platform shines in multiple clinical trials

...it can select clinically relevant cancer vaccine targets.","William Reed... ...["Evaxionu2019s proprietary AI-Immunology platform has shown in... ...Danish techbio company Evaxion Biotech has published results showing... ...positive clinical results of its AI-Immunology platform, Christian Kanstrup...

biopharma-reporter.com > article

Women in Science: Sharmeen Roy - 'pharmacy is the perfect blend of all my favourite subjects"

biopharma-reporter.com > article

BMS achieves FDA approval for schizophrenia drug Cobenfy

...Bristol Myers Squibb (BMS) acquired Karuna Therapeutics, the developer... ...In two phase 3 trials, EMERGENT-2 AND EMERGENT-3, Cobenfy reduced... ..., chief scientific officer and medical director at Segal Trials... ...in a cycle of discontinuing and switching therapies,” said Rishi Kakar...

biopharma-reporter.com > article

Eli Lilly expands manufacturing facilities in Ireland with $1.8bn investment

...Eli Lilly continues implementing the largest expansion program in... ...With a new investment in its two manufacturing sites in Ireland,... ..., executive vice president and president of Lilly Manufacturing Operations... ...Eli Lilly has announced an expansion of its manufacturing site in...

biopharma-reporter.com > article

Aurora Biosynthetics launches to boost RNA therapeutics manufacturing in Asia-Pacific

...Park Innovation District,” said Macquarie University Deputy Vice-Chancellor... ...University in Sydney, New South Wales, and the local government... ...The Asia-Pacific gene therapy market is predicted​ to reach nearly... ...increased enormously over the last five years, particularly in the Asia–Pacific...

biopharma-reporter.com > article

AI study shows GLP-1s could help prevent heart disease in millions

...Dandelion Health used its new clinical AI marketplace to analyze... ...disease (CVD) for a seven times larger population than previously... ...and CEO of Dandelion Health, highlighted the implications, he said... ...Dandelion Health, a clinical AI and real-world data (RWD) platform...

biopharma-reporter.com > article

Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence

...Novartis announced this week that the FDA has approved ribociclib... ..., who are at high risk of cancer recurrence.... ...J Slamon, Director of Clinical/Translational Research at UCLA Jonsson... ...Comprehensive Cancer Center and Chairman of the Board of Translational...

biopharma-reporter.com > article

MinervaX and Wacker Biotech partner to scale up GBS vaccine production

...As the company’s new manufacturing partner, Wacker Biotech has experience... ...over half a million preterm births annually,” said Per Fischer, CEO... ...In a statement to BioPharma Reporter, Guido Seidel, managing director... ...Related topics Downstream Processing Markets & regulation Biopharma...